Physician

Anna Dobosz, MD

According to 2025 Medicare claims, Anna Dobosz, MD (NPI: 1598022519) practices infectious disease in the Ann Arbor, MI market, with the plurality of this provider's patient population coming from Washtenaw, MI. This provider's primary affiliated billing organization is IHA HEALTH SERVICES CORPORATION (NPI: 1639423825; TIN: 383316559) and primary practice location at 48197-1051. Dobosz is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588), participating under the MSSP model.

Dobosz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 192 traditional Medicare patients, billed 405 HCPCS/CPT codes, and received $39,364 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 340 prescription claims across 53 beneficiaries totaling $325,121 in drug costs, led by Tivicay (Dolutegravir Sodium). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $61,908 and ending at $325,121. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$39K$79K2017 Medicare payment: $24,358 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $64,024 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $67,518 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $68,025 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $78,897 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $57,890 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $55,152 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $39,364 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017129279$24,358
2018283725$64,024
2019293714$67,518
2020340741$68,025
2021350867$78,897
2022282632$57,890
2023235564$55,152
2024192405$39,364

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$202K$404K2015 Drug cost: $61,908 (USD; Tot_Drug_Cst)2016 Drug cost: $403,719 (USD; Tot_Drug_Cst)2017 Drug cost: $238,229 (USD; Tot_Drug_Cst)2018 Drug cost: $97,960 (USD; Tot_Drug_Cst)2019 Drug cost: $102,278 (USD; Tot_Drug_Cst)2020 Drug cost: $211,361 (USD; Tot_Drug_Cst)2021 Drug cost: $224,001 (USD; Tot_Drug_Cst)2022 Drug cost: $188,444 (USD; Tot_Drug_Cst)2023 Drug cost: $225,229 (USD; Tot_Drug_Cst)2024 Drug cost: $325,121 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201539270$61,908
201634272$403,719
201733181$238,229
201835131$97,960
201951213$102,278
202036268$211,361
202167364$224,001
202247228$188,444
202356270$225,229
202453340$325,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes101107$133
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes3738$104
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes73137$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1720$84
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes4660$62

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TivicayDolutegravir Sodium29870$65,349
DescovyEmtricitabine/Tenofov Alafenam16480$35,277
Cefpodoxime ProxetilCefpodoxime Proxetil17547$6,405
CephalexinCephalexin371,148$977
Doxycycline HyclateDoxycycline Hyclate451,428$832

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Anna Dobosz, MD?

Tedicare shows public-source Medicare data for Anna Dobosz, MD (NPI 1598022519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anna Dobosz, MD have ACO affiliation data?

Anna Dobosz, MD is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588).

What billing organization is linked to Anna Dobosz, MD?

Anna Dobosz, MD is linked to IHA HEALTH SERVICES CORPORATION (billing NPI 1639423825) in the available physician profile data.

Does Anna Dobosz, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.